spacer
home > pmps > winter 2010 > identity, integrity, authenticity
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Identity, Integrity, Authenticity

Behind the three words of the title, there are many different meanings, and a lot of confusion, which this article will seek to clarify. This is one of the darkest areas in the industrial world, and especially the pharmaceutical industry. All project managers in this sector are currently focused on track and trace projects and ways of softly implementing new coding requirements on production lines with a minimum of immediate investment, but with enough attention to prepare the coming years and anticipated evolutions in regulation, such as aggregation.

So, identity, integrity, authenticity, track and trace, aggregation – it is worth taking some time to clarify these terms and what is it hidden behind them.

The European Federation of Pharmaceutical Industries and Associations (EFPIA) is pushing to put a unique code in place for secondary packaging, to bring an identity to each pack, even from the same batch number. By using this unique number, everybody will be able to identify one pack from another. Pack 1 and pack 2, from the same batch, produced the same day on the same production line and with the same expiry date, are different, because they have two different identities, two unique codes. This unique code defines the product itself, its production date, from which country, from which production line, its expiry date, at what point in the batch it was produced (beginning, middle or end) just as your passport defines who you are, where you are from, and so on. To conclude, a unique code defines the pack’s identity.

As a producer, you have to follow your production, not only on your production lines and plants, but also through the complete supply chain from distribution centres to retailers and to customers or patients. You have already traced your products by giving them an identity. If you’re able to check these identities along the supply chain, you’ll be able to track them. It is rather like several Customs controls at an airport. The different Customs officers will successively check your identity or passport, and are able to trace your complete trip from one country to another.

The EFPIA also recommends multiple controls to prevent counterfeiters or smugglers from introducing fake products on a legal product flow or to divert real products from their original destination to another one. To conclude this part, by defining the identity of your product and by checking it as much as possible from plant to customer, you track and trace your production.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Thierry Protas has been managing codification, serialisation, track and trace and authentication projects for more than 10 years across different sectors, but more specifically in the pharmaceutical industry. He has competencies in different fields, including printer technologies, automation devices and PLC and software project management. He joined Arjowiggins Security to use these competencies to manage security projects with customers in the pharmaceutical and agrochemical industries. Email: thierry.protas@arjowiggins.com
spacer
Thierry Protas
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Paediatric Clinical Trials

21-22 March 2012, Copthorne Tara Hotel, London, United Kingdom

Designing accurate and safe paediatric formulations is one of the topics being discussed at SMi’s Paediatric Clinical Trials held on 21st & 22nd March 2012
More info >>

 
News and Press Releases

Norwich Expands Capabilities for Phase I-III Clinical Trials

Norwich Clinical Services (NCS), a global provider of clinical research services for the pharmaceutical and biotech industries, today announced a significant expansion to its clinical research capabilities in order to meet growing market demand. Primary to the expansion, NCS unveiled a new clinical facility with capabilities to conduct all aspects of Phase I – III clinical trials including pharmacokinetics in healthy volunteers, bio-availability and bio-equivalence studies, drug metabolism studies, dose proportionality studies and multiple dose studies.
More info >>

 

 

Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.